Introduction
Controversy has existed regarding the involvement of insulin antibodies in the clinical management ofinsulin-treated patients. Virtually all diabetic patients treated with insulin develop circulating antibodies, and these are now routinely detected by a variety of techniques (1) (2) (3) (4) (5) (6) (7) .
As for all plasma components, antibody concentration is the result of equilibrium between antibody synthesis and clearance rates. The situation is probably more complex in diabetic patients because they daily receive one or several insulin (antigen) injection(s), and immune complexes made of insulin-antiinsulin antibodies are constantly formed. These HSA, human may be cleared at a higher rate than free antibodies and, as a consequence, the turnover rate of antiinsulin antibodies in the plasma compartment will be increased. In our opinion, too little attention has been paid to the dynamic aspect ofthis equilibrium, i.e., to the antibody "flux."
For instance, if IC are rapidly cleared from the plasma, an increase of daily insulin requirement matching the rate of IC clearance will allow a new steady state. In this instance, one might even expect that, if the antigen is in constant excess with regard to the antibodies, the plasma level of antibody could be low. By contrast, if the IC are slowly cleared from the plasma, little insulin will be scavenged by the macrophagic system and the daily insulin requirement should be expected to be almost normal, despite a potentially high level of plasma antibody. In this instance, if plasma antibody level is high, large amounts of insulin may be present in the plasma compartment, partly as antibody bound and partly as free (i.e., biologically active) hormone. The relative proportions between these two forms of insulin will depend on the avidity ofthe antibodies for their ligand. High-avidity antibodies will sequester their ligand in an almost nonreversible manner. By contrast low-avidity antibodies, normally in equilibrium in the presence ofa high level offree insulin, will unduly release their ligand when insulin is not metabolically needed and are likely to cause hypoglycemic episodes between meals or at night.
Thus, antibodies will act as insulin scavengers and cause insulin-resistant diabetes or (12) . The IgG2 fraction gave a single slow migrating precipitin arc in the gamma globulin region by immunoelectrophoresis against rabbit anti-whole guinea pig serum. The IgGI fraction gave one major arc in the gamma globulin region and two minor faster migrating precipitin arcs in the beta globulin region against the same rabbit antiguinea pig serum.
The guinea pig IgGl and IgG2 fractions contain very similar levels of insulin antibodies as determined by superimposable radioimmune titration and inhibition curves generated by a previously described method (13) (14) (15) . In the absence of inhibitor, 0.1 ml of each fraction diluted 1:2,300 bound 7.0 X 103 cpm 125I-ins. In the presence of 1 ng of bovine monocomponent insulin as inhibitor, 0.1 ml of each fraction at a dilution of 1:350 was required to bind 7.0 X 103 cpm of the same 12511 ins preparation (Fig. 1) . The AlIgG2 fraction induced passive immune hemolysis of insulin-coated sheep red blood cells (13) As flow rate was 4 ml/h, 10 h were required for elution of IC. As discussed later, to minimize their dissociation during the process ofchromatography, we also determined IC size by a faster technique, using Superose 6 and a fast protein liquid chromatography (FPLC) system (Pharmacia, Uppsala, Sweden) connected with an ultraviolet (UV) detector. The column was equilibrated and run with 120 mmol/liter phosphate, I mmol/liter EDTA, and 0.2 g/liter NaN3, pH 7.4. Bovine thyroglobulin (mol wt 669,000), human IgG (mol wt 158,000), BSA (mol wt 60,000), and "25I-insulin were used as molecular weight markers to calibrate the column. The samples were eluted at 0.4 ml/min, and fractions of 200 !d were collected. Absorbance at 280 nm was read by the online UV detector, and activity in each fraction was measured in a welltype counter.
In vivo animal studies with preformed IC containing '23I-insulin.
Control rats received carrier-free`23I-ins (-100 MCi) in -0.5 ml PBS containing 0.35% BSA. The experimental rats received '23I-ins (a 100 ACi in 0.1 ml) mixed with AIgG01 (0.4 ml), AIIgG2 (0.4 ml), human serum (1 ml), or whole GPAIS (40 ;d of pool 469 or 3F4 diluted 1:10 with PBS-albumin). Before injection, the various solutions were incubated at 370 for 30 min. Two experimental rats were pretreated with purified cobra venom factor (CoF; 80 Mg), an activator ofthe alternative pathway of the complement, to minimize the level of circulating factors C3 to C9 (17) . Another control group was pretreated with 6 U regular insulin to saturate the insulin receptor compartment.
'23I-Ins alone or mixed with either purified guinea pig immunoglobulin fraction or whole antiinsulin serum was injected into the jugular vein of anesthetized (60 mg/kg Pentobarbital, i.p.), fed young female Sprague-Dawley rats weighing 225-275 g. The rats were laid prone on the high-resolution parallel collimator ofa 400 T Maxi-Camera (General Electric Co., Milwaukee, WI) on-line with a Star computer system. Immediately after the injection, the data were recorded in a 128 X 128 matrix at a rate oftwo frames per minute for a period of 30 min (dynamic study). Analogue scintigraphic images were also obtained at 3, 10, 20, and 30 min.
Immediately after the 30-min dynamic study, blood was drawn by heart puncture, the liver, spleen, kidneys and stomach were rapidly dissected, and a 1-min scintigraphic image (128 X 128 matrix) of these organs, of the tube of blood, and of the remaining carcass was obtained (static study). From the static scintigraphic image ofthe dissected organs and carcass, the apparent radioactivity ofeach ofthe isolated organs and remaining carcass was measured and the respective percentages of total radioactivity was calculated. The actual injected radioactivity was measured by counting radioactivity of the syringe before and after injection with a radioisotope dose calibrator (Capintec Inc., Ramsey, NJ).
Two duplicate 0. l-ml samples ofeach serum obtained from the heart puncture blood were subjected to two separate procedures to and free 1231-iodide. Two 0. l-ml samples ofserum were treated with 25% polyethylene glycol (PEG) to precipitate the antibody-'231-ins complexes (4, 18) . To the supernatant an equal volume of 30% trichloroacetic acid (TCA) was added to precipitate the free '231-ins. The radioactivity not precipitated by the TCA was considered free '231-iodide. The other two 0. l-ml samples of serum were treated with TCA to precipitate the antibody-'23I-ins complexes plus free '231-ins. The supernate contained soluble 123I-iodide.
Dynamic images were analyzed as previously described ( 19) . Briefly, regions of interest were defined over the right upper part of the liver and the lower pole of each kidney, and the heart and time-activity curves were generated. After subtraction of appropriate background, net timeactivity curves were obtained. The ordinate of the heart curve was calibrated using the actual value of blood radioactivity (measured in a well type counter) on the blood sample taken at 30 min. The ordinate of the liver and kidney curves was expressed as percent of total injected and calibrated using the percentage ofradioactivity in the corresponding organ measured on the static image taken at 30 min.
The digital data of each of the final three curves (60 time points per curve) were transferred to an online microcomputer (Zenith Z1100), printed on paper, and stored on floppy-disc until statistically analyzed. Time-activity curves of blood and liver were compared using a BMDP program of analysis of variance of repeated measures after log transformation of the variable. Statistical differences were determined by the Snedecor test (20) . Clearance of '231-labeled IgGI or IgG2 of non-insulin-immunized guinea pig (NIgGI and NIgG2). Pure gamma globulins of non-insulin immunized guinea pig (Sigma Chemical Co., St. Louis, MO) were submitted to DEAE Sephacel anion exchange chromatography and the subclasses purified. 1 mg of each IgG subclass dissolved in 500 Al PBS was labeled with 5 mCi Na '231 using lactoperoxidase and H202. The iodination mixture was then applied on a 60 X 1.2-cm 6B Sepharose column equilibrated and developed with PBS. The fractions corresponding to the elution volume of an IgG standard were pooled. Four nembutalanesthetized rats received 100 ,Ci of 123I-NIgGl and a second group of four rats received the same amount of '231-NIgG2. Dynamic recording and data analysis were performed as previously described for IC made of antiinsulin IgG and '231I-insulin.
Rats injected with guinea pig AIIgG2 preincubated with 1231-ins sequestered virtually all ofthe radioactivity in the liver and spleen (Fig. 2) . The total radioactivity in the circulation of these rats was extremely low. The respective percentages of AIIgG2-'231-ins complexes, free '231-ins or '23iodide (degraded insulin) in the serum at 30 min were 37, 22, and 41% (Table II) . The sequestration of the radioactivity by the liver and spleen of these rats was very rapid. The scintigraph clearly demonstrates that virtually all the radioactivity was already sequestered in the liver and spleen of these rats within the first 3 min after injection. The companion scintigraph of the control rat simultaneously injected with 1231-ins alone demonstrates less radioactivity in the liver but in addition radioactivity in the kidneys and body of the rat is easily discerned (Fig. 2) .
The sequestration of virtually all the radioactivity in the liver and spleen of the AIIgG2-'23I-ins injected rats persisted throughout the scan period and was readily apparent in the very dense scintigraph images of the dissected liver and spleen but with faint images of other organs and remaining carcass taken after the 30-min dynamic scan (Fig. 3 B) . The scintigraph ofthe companion control rat exhibited only slight to moderate radioactivity in the liver and blood, no discernable radioactivity in the spleen, and prominent images of the carcass, kidneys, and stomach (Fig. 3 A) . The radioactivity in the stomach has been demonstrated to be due to 123I-iodide from the degradation of '231-ins (8, 19) . The quantitative determination of the percentage of apparent total radioactivity in the liver and spleen of the AIIgG2-1231-ins injected rat was 96% (Table III) . In comparison the bulk of the radioactivity (75-80%) in the control rats was in the carcass.
Rats injected with AIIgGl preincubated with '231-ins contained 50 times the circulating radioactivity of rats injected with AIIgG2-'231-ins. The radioactivity in the serum ofthese animals was 99% precipitable by PEG and identified as AIIgGl-231I-ins complexes (Table II) . Pooling of the AIIgGl-23I-ins complexes in the circulation is exhibited in the scintigraph taken 3 min after injection in which very dense levels of radioactivity are apparent in the heart and organs with large vascular compartments such as the liver (Fig. 4) . The control rats have much less radioactivity in the heart at 3 min (Fig. 4) . The circulating AIIgGl-_23I-ins complexes in these rats persist throughout the 30-min scan and are very apparent by the dense radioactivity in the carcass and in the blood removed by heart puncture (Fig.  3 C) Results are expressed as percent of total blood activity; mean±SD. * Expressed as cpm X 10-3/ml blood and normalized for total injected counts (as measured on the static frame taken at 30 min). * TCA-precipitable and PEG-soluble activity was taken as an estimate of '23l-insulin concentration and probably overestimates the concentration of biologically active hormone.
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Sodoyez-Goffaux et al. ofblood (Fig. 5 , Table IV ) and liver (Fig. 6 , Table IV ) generated by computer analysis ofthe dynamic study. These figures clearly show that AIIgGl-'23I-ins IC remain in the blood compartment whereas AIIgG2-1231-ins IC rapidly leave the blood compartment and are taken up by the liver. Pools ofGPAIS (469 or 3F4) contain both isotypes ofAIIgG. As expected, the blood and liver activity profiles after injection ofpreformed IC of469-'23I-ins or 3F4-123I-ins lie between those obtained with purified AIIgG subclasses but are closer to those obtained with purified AIIgG2.
Pretreatment with CoF did not modify the liver activity profile of rats injected with Pool 469-'23I-ins complexes ( Fig. 7 ; P = 0.645 for identity of area under the curves and P = 0.2743 for parallelism of the curves).
Previous saturation of the liver receptor compartment by 6 U regular insulin did not modify uptake of IC made of pool 469 and '23I-ins but markedly reduced that of 123I-insulin alone (Fig. 8) , thus demonstrating that the mechanisms involved are completely different. On one hand, clearance of IC is independent of the presence of empty insulin receptors; on the other hand, that of insulin is essentially receptor mediated.
'231-labeled IgG subclasses of normal guinea pig largely remain in the blood pool. Liver activity profiles after injection of '23I-NIgGl are slightly but significantly lower than after injection of 123I-NIgG2 ( Fig. 9 ; P = 0.0054 for identity ofareas under the curves and P = 0.6212 for parallelism of the curves). Statistical analysis also shows identity of the liver profiles obtained with 123I-NIgGl or IC made of AIIgGl and 123I-ins (P = 0.3977 for identity of areas under the curves) and a marked difference for liver profiles obtained with 123I-NMgG2 or IC made of AIIgG2 and 123I-ins (P < 0.001 for identity of areas under the curves).
Examination of Fig. 10 shows that free antinsulin antibodies have the same molecular size as purified IgG in whole serum (469), purified AIIgGl, or purified AIIgG2. $ Values for AIIgGl are statistically different from those for AIgG2 (P < 0.001). Liver and spleen activity after 469 differ from that after AIgG2 (P < 0.05 and P < 0.01, respectively).
Using the slow 6B Sepharose chromatographic system, preformed IC made with whole serum (469), purified AuIgGl, AIgG2, and '25I-ins had an apparent molecular weight of 320,000 D, a value corresponding to dimers of IgG. When the faster FPLC system was used IC appeared much larger, corresponding to aggregates of three to more than five IgG (Fig. 11) . IC had the same size whether made of whole serum or purified immunoglobulin isotypes.
Similar experiments were performed with IC made with 1231_ insulin and the two selected human serums containing cytophilic antiinsulin IgG. Fig. 12 illustrates the liver time activity curves of rats injected with preformed IC made with 1 ml of each of the two selected serums and 100 gCi '23I-insulin. With serum 1, liver activity rapidly reached circa 20% of total injected and stayed at that low level thereafter. By contrast, with serum 2, liver activity progressively increased to reach a high plateau value corresponding to circa 45% of total injected. Radiochemical analysis of blood drawn by heart puncture 30 min after IC injection showed that PEG-precipitable activity exceeded 90% of total in both cases.
The size of preformed IC made with each serum was estimated by both chromatographic methods. Using a 6B Sepharose column, IC size was intermediate between that ofIgG monomers and dimers (data not shown). Using the faster FPLC system, IC were larger. Those made with serum 1 were aggregates of three IgG or less. By contrast those ofthe second diabetic patient were larger aggregates of up to five IgG or more (Fig. 13) .
Discussion
As previously shown, 123I-insulin alone is rapidly taken up by the liver (30% of total injected after 3-4 min) and the kidneys (10-15% of total injected) and rapidly degraded in both organs.
For instance, in the liver, the half-life of radioactivity is -6 min (Fig. 8) . After 30 min, liver activity is 3-5% and kidney activity is 6-8%. After 123I-ins degradation, free 123iodide is released into the plasma, from which it is cleared by urinary ex- Table IV for statistical analysis of the data. Table IV for statistical analysis of the data. cretion and active transport by the gastric mucosa, salivary and thyroid glands, so that at a later time after '231-ins injection, e.g. 30 min, the biodistribution of radioactivity is essentially that of iodide and characterized by dense activity in the bladder, stomach, and neck (8, 19, 21) .
As shown here, the fate of antibody-bound '23I-ins is quite different and strongly influenced by the nature ofthe IgG subclass and IC size.
There is an apparent inverse relation between the level of AIIgG2 and the amount of circulating insulin antibody complexes and, conversely, a direct relation with the level ofAIIgGl in the injection bolus. On the other hand, there is a direct relationship between the amount of liver radioactivity and AIgG2 but an inverse relationship between liver binding and AIIgG1 in the injection bolus. As previously shown with autoradiographic techniques, 123I-ins alone is predominantly associated with the hepatocytes whereas '25I-ins-GPAIS complexes are essentially associatedwith the Kuppfer cells (21) . Fig. 8 clearly shows that liver uptake of '23I-ins is saturable as expected for a receptor-mediated process whereas that of 123I-ins-GPAIS complexes is independent ofthe presence of free insulin receptors. These results are in good agreement with those of others who recently showed that when insulin binds to its receptor, the insulin molecule is largely buried and only a small portion remains exposed to the solvent (22, 23) . This limited exposed portion reacts with very few monoclonal antiinsulin antibodies, and reacts with markedly decreased affinity when it does. When polyclonal antiinsulin antibodies . Experimental rats were pretreated with 6 U regular insulin to saturate the insulin receptor compartment before receiving '231-insulin alone (n = 4) or preformed immune complexes (n = 4). Note that prior injection of excess unlabeled insulin markedly inhibited hepatic uptake of 123I-insulin but did not modify that of preformed immune complexes.
are used, binding of '251I-insulin to liver plasma membranes has been found enhanced and it has been speculated that antibodies are able to cross-link occupied mobile insulin receptors and that, as a result of aggregation, insulin receptors can be activated (24, 25 Figure 9 . Liver time activity profile after i.v. injection of '23l-labeled NIgGI (n = 4) or NIgG2 (n = 4). Liver activity was slightly but significantly higher in the presence of NIgG2 than in the presence of NIgGi . Comparison with Fig. 6 shows that NIgG I and IC made of 1231-ins and specific AIIgGI yielded superimposable liver activity profiles whereas NIgG2 and IC made of specific AIIgG2 and insulin yielded markedly different liver activity profiles.
in vitro, formation of complexes of insulin receptor-insulinantiinsulin antibody is unlikely.
If insulin moiety of IC is not involved in the rapid and virtually total sequestration of AIIgG2-'23I-ins complexes in the liver, the role played by the immunoglobulin moiety should be examined.
Labeled IgGl and IgG2 of normal guinea pig are cleared at almost the same rate excluding the possibility that rapid liver uptake of '23I-ins-AIIgG2 IC is due to an IgG2 property independent of insulin binding and immune complexes formation.
It has previously been demonstrated that guinea pig AIIgG2 can bind complement and induce passive immune hemolysis of antigen-coated sheep red blood cells, whereas AIIgGl only activate late components of the complement in the absence of C 1, C4, and C2 fixation and are devoid of hemocytolytic properties (27) (28) (29) (30) (31) (32) Whichever its mechanism, aggregation is not the only factor responsible for rapid clearance of IC by the Kuppfer cells. Indeed IC made of AlIgGI and AIIgG2 have the same degree of aggregation, yet they are cleared at markedly different rates.
A third possible mechanism whereby AIIgG2 and not AIIgGl-23I-ins immune complexes are so rapidly cleared involves a particular domain ofthe Fc fragment, which reacts with specific FcyR on the macrophages (41) . It has indeed been clearly shown that guinea pig IgG2 are cytophilic for macrophages and that IgGI are not (42) (43) (44) (45) (46) 
